Skip to main content

Department of Transfusion Medicine

Symposium Description

Thirty-Eighth Annual Symposium

Description: This program is designed to provide attendees with practical information about recent developments, current practices, controversies and laboratory management issues relative to transfusion medicine.

Who Should Attend: This program will be of interest to all healthcare providers who participate in the collection, production, transfusion and monitoring of blood products.

Learning Objectives
Upon the completion of this activity, participants should be able to:

  • Describe the methods used to reinstate male donors who previously were deferred due to MSM, either since 1977 (MSM77) or more recently for 1 year (MSM 1 year), and methods used to compare the infectious disease marker rates for both MSM groups to routine blood donors as well as first-time male blood donors.
  • Report examples of European Hemovigilance and regional blood product inventory variation that which will allow a better understand of regulations and standards for blood transfusion in Europe.
  • Identify causes of ABO mistransfusion among reported fatalities and describe effective preventive measures.
  • Review the WHO initiatives to advance blood availably and safety, explain the role of regulation in national blood systems, and develop a global perspective on blood availability and safety.
  • Summarize the evidence on the role of granulocyte transfusions in the prevention and treatment of infections.
  • Develop appropriate patient and donor care strategies from examples described during case reviews.
  • Review the risk, clinical presentation and options for mitigation of bacterial contamination of platelets.
  • Review current therapies for treatment of hemoglobinopathies.

Level of Instruction
Intermediate to Advanced

Disclaimer
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of ARCBS. Information is presented for educational purposes only.

Disclosure Statement
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflicts(s) of interest or other relationships related to the content of their presentation(s). Faculty are also expected to disclose off-label and/or investigational uses of products under discussion.

We gratefully acknowledge Immucor for providing an educational grant in support of this continuing medical education activity.

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 05/31/2019

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at http://www.cc.nih.gov/disclaimers.html